17,17-Dimethyl-15-oxo-3,6,9,12,16-pentaoxaoctadecanoic acid | 929087-83-2

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 17,17-Dimethyl-15-oxo-3,6,9,12,16-pentaoxaoctadecanoic acid
• 英文别名: 2-[2-[2-[2-[3-[(2-methylpropan-2-yl)oxy]-3-oxopropoxy]ethoxy]ethoxy]ethoxy]acetic acid
• CAS: 929087-83-2
• 化学式: C₁₅H₂₈O₈
• 分子量: 336.383
• InChiKey: WWPVCFGPWNIDMX-UHFFFAOYSA-N

物化性质

• 沸点：
  447.7±35.0 °C(Predicted)
• 密度：
  1.122±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0
• 重原子数：
  23
• 可旋转键数：
  16
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.87
• 拓扑面积：
  101
• 氢给体数：
  1
• 氢受体数：
  8

反应信息

• 作为反应物：
  描述：

  17,17-Dimethyl-15-oxo-3,6,9,12,16-pentaoxaoctadecanoic acid 在 盐酸 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 以 二氯甲烷 为溶剂， 生成 3-(2-{2-[2-({[2'-(Isoxazol-5-ylsulfamoyl)-4-oxazol-2-yl-biphenyl-2-ylmethyl]-methyl-carbamoyl}-methoxy)-ethoxy]-ethoxy}-ethoxy)-propionic acid
  参考文献：
  名称：

  Chemically programmed antibodies: Endothelin receptor targeting CovX-Bodies™

  摘要：

  Aryl sulfonamide-based endothelin antagonists were synthesized and covalently linked to the reactive lysine of the m38C2 antibody to create a series of CovX-Bodies. These chemically programmed antibodies behaved as potent endothelin receptor antagonists in vitro and had antitumor efficacy in a prostate cancer xenograft model which, on a molar basis, far exceeded the activity of the parent small molecule. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2006.10.009
• 作为产物：
  描述：

  PEG5-羧酸叔丁酯,HO-PEG4叔丁酯,1-羟基-3,6,9,12-四氧杂十五烷-15-酸叔丁酯 在 jones reagent 作用下， 以 丙酮 为溶剂， 以55%的产率得到17,17-Dimethyl-15-oxo-3,6,9,12,16-pentaoxaoctadecanoic acid
  参考文献：
  名称：

  Chemically programmed antibodies: Endothelin receptor targeting CovX-Bodies™

  摘要：

  Aryl sulfonamide-based endothelin antagonists were synthesized and covalently linked to the reactive lysine of the m38C2 antibody to create a series of CovX-Bodies. These chemically programmed antibodies behaved as potent endothelin receptor antagonists in vitro and had antitumor efficacy in a prostate cancer xenograft model which, on a molar basis, far exceeded the activity of the parent small molecule. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2006.10.009

文献信息

• [EN] Trimaleimide Linkers and Uses Thereof<br/>[FR] LIEURS À BASE DE TRIMALÉIMIDE ET LEURS UTILISATION S
  申请人：NEWBIO THERAPEUTICS INC

  公开号：WO2016192528A1

  公开（公告）日：2016-12-08

  A type of trimaleimide linkers and uses thereof are disclosed. The trimaleimide linkers can be applied for preparation of antibody-drug conjugate as shown by formula I: L– (T–A–D) n Ⅰ wherein, L is an antibody, antibody fragment or protein; T is a trimaleimide linker; A is a cleavable linker group or a noncleavable linker; D is a drug; n is an integer ranging from 1 to 8.

  公开了一种三马来酰亚胺连接剂及其用途。该三马来酰亚胺连接剂可以用于制备抗体药物偶联物，如下所示的公式I：L– (T–A–D) n Ⅰ，其中，L为抗体、抗体片段或蛋白质；T为三马来酰亚胺连接剂；A为可切割连接剂基团或不可切割连接剂；D为药物；n为介于1到8之间的整数。